Thoracic Research and Practice
Original Article

Resistance Rates of Antituberculosis Drugs in Pulmonary Tuberculosis Patients Producing Mycobacterium Tuberculosis

1.

Hakkari Devlet Hastanesi, Göğüs Hastalıkları ve Tüberküloz Kliniği, Hakkari, Türkiye

2.

Trakya Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları ve Tüberküloz Anabilim Dalı, Edirne, Türkiye

3.

Onsekiz Mart Üniversitesi Tıp Fakültesi, Klinik Mikrobiyoloji Anabilim Dalı, Çanakkale, Türkiye

4.

Dörtyol Devlet Hastanesi, Göğüs Hastalıkları ve Tüberküloz Kliniği, Hatay, Türkiye

5.

İskenderun Devlet Hastanesi, Göğüs Hastalıkları ve Tüberküloz Kliniği, Hatay, Türkiye

Thorac Res Pract 2011; 12: 111-113
DOI: 10.5152/ttd.2011.25
Read: 1846 Downloads: 1165 Published: 18 July 2019

Abstract

Objective: Determination of antituberculosis drug resistance rate in pulmonary tuberculosis patients producing Mycobacterium tuberculosis.

 

Material and Method: 134 pulmonary tuberculosis patients producing Mycobacterium tuberculosis in cultures in the Trakya University Medical Faculty Hospital between the years 2005-2007 were enrolled in the study. Four major antituberculosis drugs (H, R, streptomycin (SM), ethambutol (EMB)) resistance and multidrug resistance rates were investigated. using the BACTEC 460 TB system.

 

Results: 134 pulmonary tuberculosis patients producing Mycobacterium tuberculosis were detected and 31 female patients were found and 103 male patients . Acid resistant bacilli were found in 58.2% of the patients with EZN. Antituberculosis resistance rates were established as H 10.4%, R 3%, EMB 0.7%, SM 0.7%.

 

Conclusion: It was determined that a follow up of drug resistance patterns in patients with pulmonary tuberculosis will be useful in determining treatment protocols and preventing drug resistance. (Tur Toraks Der 2011; 12: 111-3)

Files
EISSN 2979-9139